Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Tesla
TSLA
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
MDV Modiv Industrial
- 14.930
- +0.060+0.40%
Close Jan 17 16:00 ET
- 14.930
- 0.0000.00%
Post 20:01 ET
144.02MMarket Cap-135.73P/E (TTM)
15.000High14.771Low35.17KVolume15.000Open14.870Pre Close525.52KTurnover0.40%Turnover RatioLossP/E (Static)9.65MShares17.80552wk High0.77P/B131.35MFloat Cap12.52252wk Low1.15Dividend TTM8.80MShs Float66.349Historical High7.70%Div YieldTTM1.54%Amplitude7.348Historical Low14.944Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Modiv Industrial Stock Forum
• $Ardagh Metal (AMBP.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $American Express (AXP.US)$ : Edward Jones Upgrades to Buy from Hold
• $CrowdStrike (CRWD.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $Lululemon Athletica (LULU.US)$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $ResMed (RMD.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...
• $Clovis Oncology (CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience (DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology (KULR.US)$ +9.5% (secured a battery sa...
No comment yet